Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa

Movement Disorders

Volumn 11, Issue 2, 1996, Pages 214-216

  Tan, Adrian ^a,b   Salgado, Miran ^a   Fahn, Stanley ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Department of Neurology   (United States)

Author keywords

Levodopa; Parkinson's disease; Rapid eye movement sleep behavior disorder; Serotonin

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; LEVODOPA; SEROTONIN;

AGED; ARTICLE; CASE REPORT; HUMAN; MALE; MUSCLE ATONIA; PARKINSON DISEASE; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER;

AGED; ANTIPARKINSON AGENTS; HUMANS; LEVODOPA; MALE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; SLEEP DISORDERS; SLEEP, REM;

EID: 0029932794     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110216     Document Type: Article

References (16)

1. Schenck CH, Bundlie SR, Mahowald MW. Human REM sleep chronic behaviour disorders: a new category of parasomnia. Sleep Res 1985;14:208.
2. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman. REM sleep behavior disorder. In: International classification of sleep disorders: diagnostic coding manual. Rochester, MN: American Sleep Disorders Association, 1990:177-180.
3. Schenck CH, Mahowald MW. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Cleve Clin J Med 1990;57(suppl):9-23.
4. Jones BE. The organization of central cholinergic systems and their functional importance in sleep-waking states. Prog Brain Res 1993;98:61-71.
5. Culebras A, Moore JT. Magnetic resonance findings in REM sleep behavior disorder. Neurology 1989;39:1519-1523.
6. Silber MH, Ahlskog EJ. REM sleep behavior disorder in parkinsonian syndromes [Abstract]. Sleep Res 1992;21:313.
7. Tison F, Wenning GK, Quinn NP. REM sleep behavior disorder as the presenting symptom of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:379-380.
8. Schenck CH, Mahowald MW. Five cases of parkinsonism emerging after the onset of REM sleep behavior disorder (RBD) in men aged 58-79 years [Abstract]. Sleep Res 1993; 22:261.
9. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993;34:710-714.
10. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on the sleep-wake pattern in the rat. J Pharmacol Exp Ther 1993;266:726-731.
11. Trampus M, Ferri N, Adami M, Ongini E. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 1993; 235:83-87.
12. Jouvet M. Biogenic amines and the states of sleep. Science 1969;1963:32-41.
13. Imeri L, De Simoni MG, Giglio R, Clavenna A, Mancia M. Changes in the serotonergic system during the sleep-wake cycle: simultaneous polygraphic and voltammetric recordings in the hypothalamus using a telemetry system. Neuroscience 1994;58:353-358.
14. Fahn S, Libsch LR, Culter RW. Monoamines in human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea and tremor. J Neurol Sci 1971;14:427-455.
15. Fahn S, Snider S, Prasad ALN, Lane E. Normalization of brain serotonin by L-tryptophan in levodopa-treated rats. Neurology 1975;25:861-866.
16. Askenasy JJ, Yahr MD. Reversal of steep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology 1985;35:527-532.